Design
Review
These cloning milestones underpin current renal transporter-targeted therapies; leaves open identification of novel cardiorenal drug targets.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Castañeda‐Bueno et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: